Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder

This study has been terminated.
(Pfizer has terminated the execution of this protocol)
Sponsor:
Collaborator:
Pfizer
Information provided by:
Cedars-Sinai Medical Center
ClinicalTrials.gov Identifier:
NCT00836069
First received: February 3, 2009
Last updated: May 29, 2009
Last verified: May 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: April 2010
  Estimated Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)